The Impact of Arts-Based Interventions on Patient Hospital Experience
2 other identifiers
interventional
148
1 country
1
Brief Summary
nuts and bolts
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 25, 2019
CompletedFirst Posted
Study publicly available on registry
July 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedJuly 10, 2024
July 1, 2024
4.6 years
April 25, 2019
July 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Evaluate patient experience during the course of intervention using name of survey
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
Baseline at admissions
Evaluate patient experience during the course of intervention using name of survey
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
Baseline - end of week 1
Evaluate patient experience during the course of intervention using name of survey
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
week 1- week 2
Evaluate patient experience during the course of intervention using name of survey
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
week 2 - week 3
Evaluate patient experience during the course of intervention using name of survey
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
week 3 - weekly up to 10 weeks
Study Arms (4)
Patients on a high-risk obstetrics unit with an anticipated stay of two or more weeks
ACTIVE COMPARATORpatients in this group will receive twice weekly sewing and embroidery interactions with a professional artist in residence.
Patients on a bone marrow transplant unit with an anticipated stay of two or more weeks
ACTIVE COMPARATORpatients in this group will receive twice weekly visits with a professional storyteller.
HRO Standard of Care
NO INTERVENTIONSOC
BMT Standard of Care
NO INTERVENTIONSOC
Interventions
If selected for the arts activity, an artist in residence will visit you 3 times a week for a total of 3 weeks during your hospital stay. Two visits will focus on the arts activity and one visit will be the administration of the questionnaire. Each visit will be approximately 25 minutes at a time.
Eligibility Criteria
You may qualify if:
- Inpatient on either Bone Marrow Transplant ICU or High Risk Obstetrics Unit
- Estimated length of stay 2 or more weeks
- Age \>18
- Patients who will potentially benefit from the AIM experience
- For the High Risk Obstetrics Unit group (hand-sewing), patients should be physically able to participate in hand-sewing activity.
- For the Bone Marrow Transplant IUC group (story-telling/poetry), patients should be physically able to participate in story-telling/poetry activity.
You may not qualify if:
- Patient too ill
- Complex medical condition that requires therapies which would not allow time for participation
- Declined to participate
- Age \<18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberly P Kirklin, MA
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 25, 2019
First Posted
July 18, 2019
Study Start
January 1, 2019
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
At this time we do not have IRB approval to share IPD. We may change this in the future.